Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $172.3900 (-4.02%) ($169.0100 - $172.3900) on Fri. Feb. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.55% (three month average) | RSI | 62 | Latest Price | $172.3900(-4.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2.9% a day on average for past five trading days. | Weekly Trend | LGND advances 7.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(53%) IWC(52%) XBI(52%) | Factors Impacting LGND price | LGND will decline at least -2.275% in a week (0% probabilities). VIXM(-26%) UUP(-18%) VXX(-16%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.275% (StdDev 4.55%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $172.65 | 5 Day Moving Average | $197.13(-12.55%) | 10 Day Moving Average | $190.41(-9.46%) | 20 Day Moving Average | $172.65(-0.15%) | To recent high | -20.1% | To recent low | 111.8% | Market Cap | $2.77b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |